ACTIV-2: A Study for Outpatients With COVID-19
Clinical trial NCT04518410 · COMPLETED
Trial details
- NCT number
- NCT04518410
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2022-04-07
- Enrollment
- 4044
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.